Overview

Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess patient's persistency in maintaining solifenacin treatment for overactive bladder.
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Astellas Pharma Korea, Inc.
Treatments:
Solifenacin Succinate